BioPlus Acquisition (BioPlus Acquisition) Debt-to-Asset : 0.04 (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is BioPlus Acquisition Debt-to-Asset?

BioPlus Acquisition's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $0.25 Mil. BioPlus Acquisition's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $5.00 Mil. BioPlus Acquisition's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2023 was $138.63 Mil. BioPlus Acquisition's debt to asset for the quarter that ended in Jun. 2023 was 0.04.

BioPlus Acquisition Debt-to-Asset Historical Data

The historical data trend for BioPlus Acquisition's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioPlus Acquisition Debt-to-Asset Chart

BioPlus Acquisition Annual Data

Trend

Dec21

Dec22

Debt-to-Asset

0.02

BioPlus Acquisition Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Debt-to-Asset	Get a 7-Day Free Trial					0.02	0.02	0.02	0.02	0.04

Competitive Comparison of BioPlus Acquisition's Debt-to-Asset

For the Shell Companies subindustry, BioPlus Acquisition's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioPlus Acquisition's Debt-to-Asset Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, BioPlus Acquisition's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where BioPlus Acquisition's Debt-to-Asset falls into.

BioPlus Acquisition Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

BioPlus Acquisition's Debt-to-Asset for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	5)	/	238.325
	=	0.02

BioPlus Acquisition's Debt-to-Asset for the quarter that ended in Jun. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.25	+	5)	/	138.63
	=	0.04

BioPlus Acquisition (NAS:BIOSW) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

BioPlus Acquisition Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of BioPlus Acquisition's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.